NHS to roll out life-extending drug for advanced womb cancer
The NHS is going to roll out a revolutionary 30-minute treatment for advanced womb cancer for women across England.
The drug, called Dostarlimab, would benefit...
Lung cancer patients to benefit from ground-breaking new drug on NHS
Thousands of lung cancer patients in England will benefit from a ground-breaking new drug that can reduce the risk of relapse.
This follows a deal brokered...
AstraZeneca inks pact with Scorpion Therapeutics to develop medicines against cancer proteins
Global pharmaceutical and biotechnology company AstraZeneca has signed an agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against cancer proteins.
The collaboration,...
Zydus Cadila gets regulator nod to market its generic cancer drug in US
Drug maker Zydus Cadila today (June 25) received an approval from the US health regulator to market Pemetrexed injection in the American market.
Pemetrexed is...
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed...